Search results for "030215 immunology"

showing 10 items of 670 documents

Sodium chloride is an ionic checkpoint for human TH2 cells and shapes the atopic skin microenvironment.

2019

The incidence of allergic diseases has increased over the past 50 years, likely due to environmental factors. However, the nature of these factors and the mode of action by which they induce the type 2 immune deviation characteristic of atopic diseases remain unclear. It has previously been reported that dietary sodium chloride promotes the polarization of T helper 17 (T(H)17) cells with implications for autoimmune diseases such as multiple sclerosis. Here, we demonstrate that sodium chloride also potently promotes T(H)2 cell responses on multiple regulatory levels. Sodium chloride enhanced interleukin-4 (IL-4) and IL-13 production while suppressing interferon-gamma (IFN-gamma) production i…

0303 health sciencesNaive T cellSodiumT cellCellchemistry.chemical_elementGeneral MedicineAtopic dermatitismedicine.disease03 medical and health sciences0302 clinical medicinemedicine.anatomical_structurechemistryNFAT5InterferonImmunologymedicineTranscription factor030304 developmental biology030215 immunologymedicine.drug
researchProduct

Organotypic Epigenetic Signature Predicts Bone and Marrow Niche Forming Capacity of Stromal Progenitors in a Novel Mouse Model in Vivo.

2012

Abstract Abstract 2987 Mesenchymal stem/progenitor cells (MSPCs) from numerous tissues are currently tested in clinical trials despite a limited understanding of their in vivo behavior. In this study we used MSPCs from adult and fetal tissues to select the appropriate source for clinical application. We asked whether MSPCs derived from human bone marrow (BM), white adipose tissue (WAT) and umbilical cord (UC), compared to skin fibroblasts, bear an equivalent bone and marrow niche formation potential with of in vivo. Furthermore we evaluated attraction and engraftment of murine as well as human hematopoietic stem/progenitor cells (HSPCs) into newly formed MSPC-derived niches. To elucidate po…

0303 health sciencesPathologymedicine.medical_specialtyStromal cellImmunologyMesenchymal stem cellCD34Cell BiologyHematologyBiologyBiochemistryTransplantation03 medical and health sciencesHaematopoiesis0302 clinical medicinemedicine.anatomical_structuremedicineCancer researchBone marrowProgenitor cellStem cell030304 developmental biology030215 immunologyBlood
researchProduct

Biological Description of 109 Cases of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) from the French Network of BPDCN

2015

Abstract Blastic plasmacytoid dendritic cell neoplasm is a clonal disease derived from precursors of plasmacytoid dendritic cells (pDC). It is a rare neoplasm involving the skin which may or may not be associated from the outset with a leukemic component. The disease invariably progresses to aggressive leukemic dissemination, leading to a differential diagnosis with acute leukemia. In 2004, we set up a French network to recruit biological data at diagnosis. Diagnosis was according to recommendations (Swerdlow et al, 2008), with, in addition, a mandatory panel of pDC markers (Garnache-Ottou et al, 2009) detected by flow cytometry or by immunohistochemistry on infiltrated blood, bone marrow o…

0303 health sciencesPathologymedicine.medical_specialty[ SDV ] Life Sciences [q-bio][SDV]Life Sciences [q-bio]ImmunologyCell BiologyHematologyBlastic plasmacytoid dendritic cell neoplasmBiologyBiochemistry3. Good health[SDV] Life Sciences [q-bio]03 medical and health sciences0302 clinical medicineMyeloid cellsmedicineSkin lesion030304 developmental biology030215 immunology
researchProduct

cFLIPoverexpression in T cells in thymoma‐associated myasthenia gravis

2015

OBJECTIVE: The capacity of thymomas to generate mature CD4+ effector T cells from immature precursors inside the tumor and export them to the blood is associated with thymoma-associated myasthenia gravis (TAMG). Why TAMG(+) thymomas generate and export more mature CD4+ T cells than MG(-) thymomas is unknown. METHODS: Unfixed thymoma tissue, thymocytes derived thereof, peripheral blood mononuclear cells (PBMCs), T-cell subsets and B cells were analysed using qRT-PCR and western blotting. Survival of PBMCs was measured by MTT assay. FAS-mediated apoptosis in PBMCs was quantified by flow cytometry. NF-κB in PBMCs was inhibited by the NF-κB-Inhibitor, EF24 prior to FAS-Ligand (FASLG) treatment …

0303 health sciencesThymomamedicine.diagnostic_testApoptosis Inhibitorbusiness.industryGeneral Neurosciencemedicine.diseasePeripheral blood mononuclear cellMyasthenia gravisFlow cytometryBlot03 medical and health sciences0302 clinical medicineApoptosishemic and lymphatic diseasesImmunologymedicineCancer researchMTT assayNeurology (clinical)businessResearch Articles030304 developmental biology030215 immunologyAnnals of Clinical and Translational Neurology
researchProduct

Are Polyfunctional Cells Protective in M. tuberculosis Infection?

2012

Tuberculosis (TB) continues to claim almost 2 million lives each year, and causes active TB disease in over 9 million new cases yearly. Control of TB is further impeded by the strong increase in TB morbidity and mortality due to HIV co-infection, and the rise of multi-drug resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis (Mtb) strains (WHO. Global tuberculosis control: surveillance, planning, financing: WHO 10 report 2008). Clinical disease does not develop in the vast majority (90-98%) of all Mtb infected individuals, providing compelling evidence that the human system is capable of controlling the pathogen. However, these clinically asymptomatic subjects do …

0303 health sciencesTuberculosisbiologybusiness.industryHuman immunodeficiency virus (HIV)Diseasemedicine.disease_causebiology.organism_classificationmedicine.diseaseClinical diseaseAsymptomaticVirology3. Good healthMycobacterium tuberculosis03 medical and health sciences0302 clinical medicinemedicineTuberculosis controlmedicine.symptombusinessPathogen030304 developmental biology030215 immunology
researchProduct

Alternative NF-κB signaling regulates mTEC differentiation from podoplanin-expressing precursors in the cortico-medullary junction

2015

The thymic epithelium forms specialized niches to enable thymocyte differentiation. While the common epithelial progenitor of medullary and cortical thymic epithelial cells (mTECs and cTECs) is well defined, early stages of mTEC lineage specification have remained elusive. Here, we utilized in vivo targeting of mTECs to resolve their differentiation pathways and to determine whether mTEC progenitors participate in thymocyte education. We found that mTECs descend from a lineage committed, podoplanin (PDPN)-expressing progenitor located at the cortico-medullary junction. PDPN(+) junctional TECs (jTECs) represent a distinct TEC population that builds the thymic medulla, but only partially supp…

0303 health scienceseducation.field_of_studyImmunologyPopulationGene targetingBiologyCell biology03 medical and health sciencesThymocyte0302 clinical medicinePodoplaninImmunologyImmunology and AllergyCentral toleranceProgenitor celleducationPDPN030304 developmental biology030215 immunologyProgenitorEuropean Journal of Immunology
researchProduct

2006

Prior studies demonstrate that adenosine, acting at one or more of its receptors, mediates the anti-inflammatory effects of methotrexate in animal models of both acute and chronic inflammation. Both adenosine A2A and A3 receptors contribute to the anti-inflammatory effects of methotrexate treatment in the air pouch model of inflammation, and the regulation of inflammation by these two receptors differs at the cellular level. Because different factors may regulate inflammation at different sites we examined the effect of low-dose weekly methotrexate treatment (0.75 mg/kg/week) in a model of acute peritoneal inflammation in adenosine A2A receptor knockout mice and A3 receptor knockout mice an…

0303 health sciencesmedicine.medical_specialtybusiness.industryImmunologyAdenosine A2A receptorInflammationAdenosine A3 receptorAdenosine3. Good health03 medical and health sciencesInterleukin 100302 clinical medicineEndocrinologyRheumatologyInternal medicineKnockout mousemedicineImmunology and AllergyTumor necrosis factor alphamedicine.symptombusinessReceptor030304 developmental biology030215 immunologymedicine.drugArthritis Research & Therapy
researchProduct

Impact of Donor Type on Outcome after Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia Patients: Analysis of the German-Austrian Acute …

2014

Abstract Background:Despite recent advances in identifying novel molecular targets in AML patients, intensive chemotherapy followed by allogeneic hematopoietic stem cell transplantation (HSCT) still remains a cornerstone of AML therapy. However, outcome of HSCT depends on the availability of a donor and the donor type. Prior studies comparing HSCT from HLA-matched related donors (MRD) with matched unrelated donors (MUD), demonstrated conflicting results with regards to outcome. These conflicting results might be attributed to the genetic heterogeneity of AML. Aims:To analyze outcome with respect to donor type of 952 AML patients who received HSCT in first complete remission (CR) and were tr…

0303 health sciencesmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentImmunologySignificant differenceComplete remissionMyeloid leukemiaCell BiologyHematologyHematopoietic stem cell transplantationBiochemistry3. Good healthTransplantation03 medical and health sciences0302 clinical medicineRisk groupsInternal medicineMolecular targetsmedicineCumulative incidencebusiness030304 developmental biology030215 immunologyBlood
researchProduct

Does dietary salt induce autoimmunity?

2013

Two recent publications suggest that dietary salt may polarize TH17 cells and therefore increase the risk of developing autoimmune disease. Where low salt diets can readily be tested for their therapeutic effects in autoimmune disease, more work is needed to connect dietary salts with the development of immunopathology.

610 Medicine & healthBiology10263 Institute of Experimental Immunologymedicine.disease_causeImmediate early proteinAutoimmunity1307 Cell Biology03 medical and health sciences0302 clinical medicineLow-salt dietsImmunopathology1312 Molecular BiologymedicineMolecular Biology030304 developmental biologyAutoimmune disease0303 health sciencesCell Biologymedicine.diseaseResearch Highlight3. Good healthImmunology570 Life sciences; biologyInterleukin 17030215 immunologyDietary saltCell research
researchProduct

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target

2018

Blastic Plasmacytoid Dendritic Cell Neoplasm is a rare and aggressive hematological malignancy currently lacking an effective therapy. To possibly identify genetic alterations useful for a new treatment design, we analyzed by whole-exome sequencing fourteen Blastic Plasmacytoid Dendritic Cell Neoplasm patients and the patient-derived CAL-1 cell line. The functional enrichment analysis of mutational data reported the epigenetic regulatory program as the most significantly undermined (P<.0001). In particular, twenty-five epigenetic-modifiers were found mutated (e.g., ASXL1, TET2, SUZ12, ARID1A, PHF2, CHD8); ASXL1 was the most frequently affected (28.6% of cases). To evaluate the impact of …

Acute Myeloid LeukemiaBlastic plasmacytoid dendritic cell neoplasm epigenetic mutationsSkin NeoplasmsAzacitidineDecitabinePlasmacytoid dendritic cellGene mutationBiologyDecitabineBPDCNArticleEpigenesis Genetic03 medical and health sciences0302 clinical medicineHistone methylation5’-Azacytidine; Acute Myeloid Leukemia; BPDCN; Decitabine; WESmedicineHumansEpigeneticsExome sequencingRegulation of gene expressionMyeloproliferative DisordersDendritic CellsGenomicsHematology5 -AzacytidineMyeloid Neoplasms5’-AzacytidineCancer researchWES030215 immunologymedicine.drugHaematologica
researchProduct